(Q35917135)

11 August 2017

1 reference

title

Combating infections in hematopoietic stem cell transplant recipients (English)

1 reference

11 August 2017

1

W Garrett Nichols

1 reference

11 August 2017

1 June 2003

1 reference

Expert Review of Anti-infective Therapy

11 August 2017

1 reference

11 August 2017

1

1 reference

11 August 2017

1

1 reference

11 August 2017

57-73

1 reference

Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis

11 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Is monotherapy for febrile neutropenia still a viable alternative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Clostridium difficile--Associated diarrhea: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Diagnosis of fungal infection: new technologies for the mycology laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Acyclovir prophylaxis of herpes-simplex-virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Transferred herpes simplex virus immunity after stem-cell transplantation: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Post-transplant lymphoproliferative disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Pathogenesis and management of polyomavirus infection in transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

PCR for the diagnosis of toxoplasmosis after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.57

21 January 2018

Identifiers

DOI

10.1586/14787210.1.1.57

1 reference

11 August 2017

1 reference

PubMed ID

15482102